Societal CDMO Inc
F:RAH

Watchlist Manager
Societal CDMO Inc Logo
Societal CDMO Inc
F:RAH
Watchlist
Price: 1.58 EUR Market Closed
Market Cap: 165.5m EUR

Wall Street
Price Targets

RAH Price Targets Summary
Societal CDMO Inc

There are no price targets for RAH.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Societal CDMO Inc Competitors:
Price Targets
NATCOPHARM
Natco Pharma Ltd
2% Upside
512
Grand Pharmaceutical Group Ltd
50% Upside
4568
Daiichi Sankyo Co Ltd
69% Upside
300558
Betta Pharmaceuticals Co Ltd
37% Upside
ACB
Aurora Cannabis Inc
31% Upside
CLN
Celon Pharma SA
35% Upside
PFIZER
Pfizer Ltd
25% Upside
000999
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
35% Upside

Revenue
Forecast

Revenue Estimate
Societal CDMO Inc

For the last 8 years the compound annual growth rate for Societal CDMO Inc's revenue is 8%. The projected CAGR for the next 3 years is 6%.

8%
Past Growth
6%
Estimated Growth
Estimates Accuracy
0%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Societal CDMO Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
Societal CDMO Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-71%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RAH's stock price target?
Not Available

RAH doesn't have any price targets made by Wall Street professionals.

What is Societal CDMO Inc's Revenue forecast?
Projected CAGR
6%

For the last 8 years the compound annual growth rate for Societal CDMO Inc's revenue is 8%. The projected CAGR for the next 3 years is 6%.

Back to Top